# EDGAR Filing Document

**Accession Number:** 0001858327
**File Stem:** 0000000000-23-002472
**Filing Date:** 2023-3
**Character Count:** 19911
**Document Hash:** 6d973a7fbad2d5d0370e0b6a4248d146
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-002472.hdr.sgml**: 20230505

**ACCESSION NUMBER**: 0000000000-23-002472

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230314

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** dMY Technology Group, Inc. VI
- **CENTRAL INDEX KEY:** 0001858327
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 863312690
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 1180 NORTH TOWN CENTER DRIVE
- **STREET 2:** SUITE 100
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89144
- **BUSINESS PHONE:** 7027814313

**MAIL ADDRESS:**
- **STREET 1:** 1180 NORTH TOWN CENTER DRIVE
- **STREET 2:** SUITE 100
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89144

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TdMY Technology Group, Inc.
- **DATE OF NAME CHANGE:** 20210421
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-22-311022

## Text-Extract

```

United States securities and exchange commission logo

                              March 14, 2023

       Harry You
       Chairman
       dMY Technology Group, Inc. VI
       1180 North Town Center Drive, Suite 100
       Las Vegas, Nevada 89144

                                                        Re: dMY Technology
Group, Inc. VI
                                                            Schedule TO-I/A
                                                            Filed March 3, 2023
                                                            File No. 005-92918

       Dear Harry You:

              We have reviewed your filing and have the following comments. In
some of our
       comments, we may ask you to provide us with information so we may better
understand your
       disclosure.

              Please respond to these comments within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comments apply to your facts and circumstances, please tell us why in
your response.

              After reviewing your response to these comments, we may have
additional
       comments. Unless we note otherwise, our references to prior comments are
to comments in our
       February 16, 2023 letter.

       Exhibit 99.(a)(1)(C) to Schedule TO

       Risk Factors
       dMY VI's Amended and Restated Certificate of Incorporation..., page 17

   1.                                                   We note your response
to prior comment 4. Please expand your risk factor to address the
                                                        fact that the exclusive
forum provision in your certificate of incorporation is not
                                                        applicable to claims
arising under the Exchange Act.
       You may not have the same benefits as an investor in an underwritten
public offering..., page 18

   2.                                                   To better illustrate
the risk being conveyed by this risk factor, highlight the significant
                                                        disparity between the
purchase price being paid for Rainwater Tech by the SPAC and the
                                                        valuation of Rainwater
Tech.
 Harry You
FirstName  LastNameHarry   You
dMY Technology    Group, Inc. VI
Comapany
March      NamedMY Technology Group, Inc. VI
       14, 2023
March2 14, 2023 Page 2
Page
FirstName LastName
Background of the Business Combination
dMY VI's Board of Directors' Reasons for the Approval of the Business
Combination
Valuation Analysis, page 79

3.       Address how the board and its financial advisors considered the
uncertainty of Rainwater
         Tech's technology to generate rainfall on a commercial basis in
determining the valuation.
4.       Please expand your discussion of your valuation analysis to address
the limitations and
         attainability of your predictions, including the factors or
contingencies that would affect
         such growth from ultimately materializing.
Management's Discussion and Analysis of Financial Condition and Results of
Operations of
DMY VI
Critical Accounting Policies and Estimates, page 110

5.       You state that you have identified "the following" as your critical
accounting policies,
         however, you do not include a discussion of any specific estimates.
Please explain or
         revise. Also, refer to this section as Critical Accounting Estimates
both here and on page
         132. Refer to Item 303(b)(3) of Regulation S-K.
Underwriting Agreement, page 110

6.       We understand that Goldman Sachs, the lead underwriter in your SPAC
IPO, intends to
         waive the deferred underwriting commissions that would otherwise be
due to it upon the
         closing of the business combination. Please disclose how this waiver
was obtained, why
         the waiver was agreed to, and clarify the SPAC's current relationship
with Goldman
         Sachs. Revise your relevant disclosure referring to the payment of
deferred underwriting
         commissions.
7.       Please describe what relationship existed between Goldman Sachs and
the SPAC after the
         close of the IPO, including any financial or merger-related advisory
services conducted by
         Goldman Sachs. For example, clarify whether Goldman Sachs had any role
in the
         identification or evaluation of business combination targets.
8.       Tell us whether Goldman Sachs was involved in the preparation of any
disclosure that is
         included in the Offer, including any analysis underlying disclosure.
If so, clarify their
         involvement, whether they have retracted any work product associated
with the
         transaction, and the risk of such withdrawal and reliance on their
expertise. Further, please
         clarify that Goldman Sachs claims no role in the SPAC   s business
combination
         transaction and has affirmatively disclaimed any responsibility for
any of the disclosure in
         this filing.
9.       Please tell us whether you are aware of any disagreements with Goldman
Sachs regarding
         the disclosure in the Offer. Further, please add risk factor
disclosure that clarifies that
         Goldman Sachs was to be compensated, in part, on a deferred basis for
its underwriting
         services in connection with the SPAC IPO and such services have
already been rendered,
 Harry You
FirstName  LastNameHarry   You
dMY Technology    Group, Inc. VI
Comapany
March      NamedMY Technology Group, Inc. VI
       14, 2023
March3 14, 2023 Page 3
Page
FirstName LastName
         yet Goldman Sachs is waiving such fees and disclaiming responsibility
for the Offer.
         Clarify the unusual nature of such a fee waiver and the impact of it
on the evaluation of
         the business combination.
10.      Disclose whether Goldman Sachs provided you with any reasons for the
fee waiver. If
         there was no dialogue and you did not seek out the reasons why Goldman
Sachs was
         waiving deferred fees, despite already completing their services,
please indicate so in the
         Offer. Further, revise the risk factor disclosure to explicitly
clarify that Goldman
         Sachs has performed all their obligations to obtain the fee and
therefore is gratuitously
         waiving the right to be compensated.
11.      We note your disclosure that you agreed to pay Needham fees to be
mutually agreed upon
         at a later date, solely in the event you complete your business
combination and that as of
         December 31, 2022, you determined that a business combination is not
considered
         probable. Please clarify whether any fees have already been paid to
Needham in
         connection with services already provided to the SPAC in this
transaction. Furthermore,
         clarify why the business combination is not considered probable in
light of the fact that
         the board is recommending a business combination that is not subject
to shareholder
         approval.
Unaudited Pro Forma Condensed Combined Financial Information, page 137

12.      We note from the subsequent events footnotes on pages F-25 and F-38
that both dMY IV
         and Rainwater Tech incurred additional related party debt since fiscal
year end. Please
         tell us your consideration to reflect such amounts in your pro forma
financial statements.
          We also note that the dMY's working capital loans will either be
repaid upon
         consummation of a business combination, or at the lenders discretion,
up to $1.5 million
         of such loans may be convertible into warrants of the post business
combination entity.
         Please tell us how the repayment of such loans is reflected in the pro
forma financial
         statements or revise as necessary.
13.      We note from your revised disclosures on page 114 that you have agreed
to pay
         Needham fees in the event that you complete the business combination.
Please tell us the
         amount or range of fees that will be paid upon consummation of the
merger. Also, tell us
         whether these fees are included in pro forma adjustment (aa) and if
not, revise to reflect
         such fees as part of the purchase business combination transaction
costs.
DMY Technology Group, Inc VI Financial Statements, page F-1

14.      We note your response to prior comment 22 as it relates to the $8.5
million waiver of
         deferred underwriting commissions as a gain from extinguishment of
deferred
         underwriting commissions. Considering you appeared to have originally
recorded the
         deferred underwriting commissions as a reduction of equity, tell us
whether you
         considered reflecting any portion of this settlement as an equity
adjustment and why such
         accounting treatment was dismissed in light of the guidance in ASC
420-10-40-1. In this
         regard, your response does not appear to support why you have not
recorded the credit
 Harry You
dMY Technology Group, Inc. VI
March 14, 2023
Page 4
       side of the transaction through equity.
        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

        You may contact Chen Chen, Staff Accountant, at 202-551-7351, or
Kathleen Collins,
Accounting Branch Chief, at 202-551-3499, if you have questions regarding
comments on the
financial statements and related matters. Please contact David Plattner,
Special Counsel, at 202-
551-8094, with questions regarding tender offer rules and schedules. Please
contact Alexandra
Barone, Staff Attorney, at 202-551-8816, or Larry Spirgel, Office Chief, at
202-551-3815, with
any other questions.

                                                             Sincerely,
FirstName LastNameHarry You
                                                             Division of
Corporation Finance
Comapany NamedMY Technology Group, Inc. VI
                                                             Office of
Technology
March 14, 2023 Page 4
cc:       Adam Brenneman
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

March 14, 2023

Harry You  
Chairman  
dMY Technology Group, Inc. VI  
1180 North Town Center Drive, Suite 100  
Las Vegas, Nevada 89144

**Re: dMY Technology Group, Inc. VI  
Schedule TO-I/A  
Filed March 3, 2023  
File No. 005-92918**

Dear Harry You:

We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response.

After reviewing your response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our February 16, 2023 letter.

Exhibit 99.(a)(1)(C) to Schedule TO

# Risk Factors

dMY VI's Amended and Restated Certificate of Incorporation..., page 17

1. We note your response to prior comment 4. Please expand your risk factor to address the fact that the exclusive forum provision in your certificate of incorporation is not applicable to claims arising under the Exchange Act.

You may not have the same benefits as an investor in an underwritten public offering..., page 18

2. To better illustrate the risk being conveyed by this risk factor, highlight the significant disparity between the purchase price being paid for Rainwater Tech by the SPAC and the valuation of Rainwater Tech.

Harry You
dMY Technology Group, Inc. VI
March 14, 2023
Page 2

# Background of the Business Combination

# dMY VI's Board of Directors' Reasons for the Approval of the Business Combination Valuation Analysis, page 79

3. Address how the board and its financial advisors considered the uncertainty of Rainwater Tech's technology to generate rainfall on a commercial basis in determining the valuation.
4. Please expand your discussion of your valuation analysis to address the limitations and attainability of your predictions, including the factors or contingencies that would affect such growth from ultimately materializing.

# Management's Discussion and Analysis of Financial Condition and Results of Operations of DMY VI

# Critical Accounting Policies and Estimates, page 110

5. You state that you have identified "the following" as your critical accounting policies, however, you do not include a discussion of any specific estimates. Please explain or revise. Also, refer to this section as Critical Accounting Estimates both here and on page 132. Refer to Item 303(b)(3) of Regulation S-K.

# Underwriting Agreement, page 110

6. We understand that Goldman Sachs, the lead underwriter in your SPAC IPO, intends to waive the deferred underwriting commissions that would otherwise be due to it upon the closing of the business combination. Please disclose how this waiver was obtained, why the waiver was agreed to, and clarify the SPAC's current relationship with Goldman Sachs. Revise your relevant disclosure referring to the payment of deferred underwriting commissions.
7. Please describe what relationship existed between Goldman Sachs and the SPAC after the close of the IPO, including any financial or merger-related advisory services conducted by Goldman Sachs. For example, clarify whether Goldman Sachs had any role in the identification or evaluation of business combination targets.
8. Tell us whether Goldman Sachs was involved in the preparation of any disclosure that is included in the Offer, including any analysis underlying disclosure. If so, clarify their involvement, whether they have retracted any work product associated with the transaction, and the risk of such withdrawal and reliance on their expertise. Further, please clarify that Goldman Sachs claims no role in the SPAC's business combination transaction and has affirmatively disclaimed any responsibility for any of the disclosure in this filing.
9. Please tell us whether you are aware of any disagreements with Goldman Sachs regarding the disclosure in the Offer. Further, please add risk factor disclosure that clarifies that Goldman Sachs was to be compensated, in part, on a deferred basis for its underwriting services in connection with the SPAC IPO and such services have already been rendered,

Harry You
dMY Technology Group, Inc. VI
March 14, 2023
Page 3

yet Goldman Sachs is waiving such fees and disclaiming responsibility for the Offer. Clarify the unusual nature of such a fee waiver and the impact of it on the evaluation of the business combination.

10. Disclose whether Goldman Sachs provided you with any reasons for the fee waiver. If there was no dialogue and you did not seek out the reasons why Goldman Sachs was waiving deferred fees, despite already completing their services, please indicate so in the Offer. Further, revise the risk factor disclosure to explicitly clarify that Goldman Sachs has performed all their obligations to obtain the fee and therefore is gratuitously waiving the right to be compensated.

11. We note your disclosure that you agreed to pay Needham fees to be mutually agreed upon at a later date, solely in the event you complete your business combination and that as of December 31, 2022, you determined that a business combination is not considered probable. Please clarify whether any fees have already been paid to Needham in connection with services already provided to the SPAC in this transaction. Furthermore, clarify why the business combination is not considered probable in light of the fact that the board is recommending a business combination that is not subject to shareholder approval.

Unaudited Pro Forma Condensed Combined Financial Information, page 137

12. We note from the subsequent events footnotes on pages F-25 and F-38 that both dMY IV and Rainwater Tech incurred additional related party debt since fiscal year end. Please tell us your consideration to reflect such amounts in your pro forma financial statements. We also note that the dMY's working capital loans will either be repaid upon consummation of a business combination, or at the lenders discretion, up to $1.5 million of such loans may be convertible into warrants of the post business combination entity. Please tell us how the repayment of such loans is reflected in the pro forma financial statements or revise as necessary.

13. We note from your revised disclosures on page 114 that you have agreed to pay Needham fees in the event that you complete the business combination. Please tell us the amount or range of fees that will be paid upon consummation of the merger. Also, tell us whether these fees are included in pro forma adjustment (aa) and if not, revise to reflect such fees as part of the purchase business combination transaction costs.

DMY Technology Group, Inc VI Financial Statements, page F-1

14. We note your response to prior comment 22 as it relates to the $8.5 million waiver of deferred underwriting commissions as a gain from extinguishment of deferred underwriting commissions. Considering you appeared to have originally recorded the deferred underwriting commissions as a reduction of equity, tell us whether you considered reflecting any portion of this settlement as an equity adjustment and why such accounting treatment was dismissed in light of the guidance in ASC 420-10-40-1. In this regard, your response does not appear to support why you have not recorded the credit

Harry You  
dMY Technology Group, Inc. VI  
March 14, 2023  
Page 4

side of the transaction through equity.

We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

You may contact Chen Chen, Staff Accountant, at 202-551-7351, or Kathleen Collins, Accounting Branch Chief, at 202-551-3499, if you have questions regarding comments on the financial statements and related matters. Please contact David Plattner, Special Counsel, at 202-551-8094, with questions regarding tender offer rules and schedules. Please contact Alexandra Barone, Staff Attorney, at 202-551-8816, or Larry Spirgel, Office Chief, at 202-551-3815, with any other questions.

Sincerely,

Division of Corporation Finance Office of Technology

cc: Adam Brenneman